体外診断薬 (IVD) の動向と市場の最新情勢 (2022年11月)

診断用検査薬の重要性はかつてないほど高まっています。検査需要や現行技術・新技術の動きは、体外診断用医薬品市場のほとんどの領域で引き続き勢いを増しています。新製品や世界の医療支出の変化、主要市場における規制の変更、疾患動向といった要因が、市場の全体像を刷新し続けています。市場には、業界の注目を集める成長分野もあります。その中には、次世代シーケンサー (NGS)、個別化医療、質量分析などがあります。また、免疫化学、ポイントオブケア (POC) 検査、分子診断学も市場の関心が高く、IVDの将来における中核となることが予想される分野です。体外診断用医薬品市場は、絶え間ない技術革新により、ダイナミックな動きを続けています。

当レポートでは、世界の体外診断薬 (IVD) 市場の最新動向 (2022年11月現在) について分析し、全体的な市場規模の動向見通し、市場の主な促進・抑制要因 (2022年第3四半期および下半期)、新製品の開発・発売動向、新型コロナウイルス感染症 (COVID-19) の影響、今後の製品開発・市場開拓の可能性、といった情報を取りまとめてお届けいたします。

目次

第1章 世界のIVD市場 (2022年11月更新)

• IVD市場の需要と成長
• COVID-19診断市場
• 市場セグメントに対するCOVID-19の影響

第2章 製品の動向と新規開発

• 主要な新製品 (2022年第3四半期)：コアIVD製品の発売・開発・動向
• 臨床化学
• フローサイトメトリー
• イムノアッセイ
• 質量分析
• 分子
• 個別化医療
• POC
• シーケンシング
• 新型コロナウイルス感染症 (COVID-19) 関連の主要動向 (2022年第3四半期)
• 抗原・抗体
• 分子

第3章 大手IVD企業の業績

• 主要な競合リーダーの最新動向
• 第3四半期の企業合併・買収 (M&A) 活動
• Abbott Laboratories
• Becton Dickinson and Co
• bioMérieux SA
• Danaher Corporation
• Hologic, Inc.
• QuidelOrtho Corporation
• Roche Diagnostic
• Siemens Healthineers
• Sysmex Corporation
• Thermo Fisher Scientific

第4章 新たな機会

• 人工知能の今後の動向
• 在宅検査
• IVDにおけるマイクロフルイディクス
• 遠隔医療

Key Questions answered in this report:

• What's Driving Growth in the IVD Market in Q3 and the last half of 2022?

• What Major Trends are Affecting the Market in Q3 and the last half of 2022?

• How Has COVID-19 Impacted and Continued to Impact the Market in Q3 and the last half of 2022?

• What Product Trends and New Developments Will Shape the IVD Market in the last half of 2022?

Diagnostic test products have never been more important. This report is an update of the market for in vitro diagnostics products from Kalorama's analysts to reflect the latest information as of Q3 2022 with a publication date of November 2022.

The demand for testing and movement of current and new technologies has continued to demonstrate gains in most areas of the IVD market. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly evolving market picture. There are some growing segments in the market that have attracted industry attention. Among these are next-generation sequencing (NGS), personalized medicine and mass spectrometry. Immunochemistry, point-of-care (POC) testing, and molecular diagnostics are also segments of great market interest, anticipated to be a core part of the future of IVD. The IVD market remains dynamic, demonstrating constant innovations.

Kalorama Information continues to be diligent in outlining the IVD market and its rapidly changing landscape. Kalorama Information has been and continues to be superior in accessing the market due to the extensive experience of its authors and commitment by the company to present the most accurate data available.

Table of Contents

Chapter 1: Worldwide IVD Market - November 2022 Update

• IVD Market Demand and Growth
  • Figure 1-1: Quarter-by-Quarter Segment Performance Commentary, 2022
  • Table 1-1: Global In Vitro Diagnostic Sales by Product Market, 2022 ($ million) (Clinical Chemistry; Immunoassays - non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology (ID/AST); Microbiology (molecular); Microbiology - Mass Spectrometry; Coagulation (PT/INR); Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry; Other IVD)
  • Figure 1-2: IVD Segment Performance, Q1 2022 - Q4 2022e ($MN)
  • Figure 1-3: IVD Segment Performance, Total Market Value, 2022 ($MN)
• COVID-19 Diagnostic Markets
  • Table 1-2: COVID-19 Product Sales - Immunoassay (Antigen, Serology), Molecular, Rapid - 2022 ($ millions)
• Effect of COVID-19 on Market Segments
  • Table 1-3: IVD Market excluding and with COVID-19, 2022
  • Figure 1-4: IVD Market Distribution by Segment, 2022
  • Figure 1-5: IVD Market by COVID-19 and non-COVID markets, Quarterly Performance, 2022
  • Table 1-4: Global In Vitro Diagnostic Market - YoY Growth 2021-2022
  • Figure 1-6: Global In Vitro Diagnostic Market - YoY Growth 2021-2022

Chapter 2: Product Trends and New Developments

• Selected New - Q3 2022 - Core IVD Product Launches, Developments and Trends
• Clinical Chemistry
• Flow Cytometry
• Immunoassay
• Mass Spectrometry
• Molecular
• Personalized Medicine
• POC
• Sequencing
• Selected COVID-19 Developments - Q3 2022
  • Figure 2-1: COVID-19 Test Market by Type, Q1-Q3 2022 - COVID-19 Testing Wanes
• Antigen/Antibody
• Molecular

Chapter 3: Top IVD Market Participant Results

• Selected Competitive Leader Updates
  • Figure 3-1: IVD Segment Growth by Leading Competitors, Change in Sales 2021-2022
  • Figure 3-2: Changes in Market Distribution for IVD Sales, 2019 - 2022 - Roche and Abbott Battle for #1 Spot
  • Figure 3-3: Comparison of Total Diagnostic Sales for Abbott vs Roche 2020-2022 (in millions $)
• Q3 M&A Activity
  • Table 3-1: IVD-Relevant M&A Activity, 2022
  • Figure 3-4: Count of IVD Industry M&A Deals by Month, 2022
• Abbott Laboratories
  • Table 3-2: Abbott Corporate Summary
• Becton Dickinson and Co
  • Table 3-3: Becton Dickinson Corporate Summary
• bioMérieux SA
  • Table 3-4: bioMérieux Corporate Summary
• Danaher Corporation
  • Table 3-5: Danaher Corporation Summary
• Hologic, Inc.
  • Table 3-6: Hologic Corporate Summary
• QuidelOrtho Corporation
  • Table 3-7: QuidelOrtho Corporate Summary
• Roche Diagnostic
  • Table 3-8: Roche Diagnostic Corporate Summary
• Siemens Healthineers
  • Table 3-9: Siemens Healthineers Corporate Summary
• Sysmex Corporation
  • Table 3-10: Sysmex Corporate Summary
• Thermo Fisher Scientific
  • Table 3-11: Thermo Fisher Scientific Corporate Summary

Chapter 4: New Opportunities

• Artificial Intelligence Future Trends
• At-Home Testing
• Microfluidics in IVD
• Telehealth